RxDoctor Payments Data

Laura Dressel, MD

Family Medicine · Candler, NCNPI 1528001898

Payments from drug & device makers

$5,418in general payments, 2019–2025

Across 327 payments — averaging $16.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$644
  • Novo Nordisk$595
  • AbbVie$533
  • GSK$529
  • Amgen$369
  • AstraZeneca$342
  • plus $2K from 37 others

What the payments were for

  • Food & beverage$5,409100%
  • Education$90%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,418 in reported general payments places this provider in the 90th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$176,922
Medicare patients
368
Services billed
4,380

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban110$103,437
FarxigaDapagliflozin Propanediol95$95,597
OzempicSemaglutide87$92,375
XareltoRivaroxaban56$62,084
JardianceEmpagliflozin52$62,074
Trelegy ElliptaFluticasone/Umeclidin/Vilanter53$50,201
ProliaDenosumab15$26,322
Tresiba Flextouch U-200Insulin Degludec20$18,323
OxycontinOxycodone Hcl22$17,862
Repatha SureclickEvolocumab21$16,468
EntrestoSacubitril/Valsartan12$16,188
Breztri AerosphereBudesonide/Glycopyr/Formoterol26$16,145
MyrbetriqMirabegron26$16,003
Stiolto RespimatTiotropium Br/Olodaterol Hcl24$13,864
TrulicityDulaglutide12$11,499

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$342$111,742121 claims
PfizerEliquis, Abrysvo$644$108,950127 claims
Novo NordiskOzempic$595$92,37587 claims
Boehringer IngelheimJardiance, Stiolto Respimat$164$75,93876 claims
GSKTrelegy Ellipta, Arexvy, Shingrix, Arnuity Ellipta$529$66,695118 claims
Johnson & JohnsonXarelto$47$62,08456 claims
AmgenProlia$369$26,32215 claims
NovartisEntresto$53$16,18812 claims
Astellas Pharma US IncMyrbetriq$104$16,00326 claims
AbbVieLinzess, Synthroid$533$15,26754 claims
Lilly USA, LLCTrulicity$305$11,49912 claims
MerckBelsomra$41$9,33420 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Candler

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →